Clinical Trial Update: Dose Escalation Pilot Study to Evaluate the Safety of Alocyte for the Treatment of Facetogenic Back Pain [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation study is evaluating the safety of Alocyte for facetogenic back pain and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Back Pain
• Facet Joint Osteoarthritis
• Facet Joint Pain

Drugs mentioned

• Alocyte

Snippet

Sponsor: Alimorad Farshchian | Conditions: Facet Joints; Degeneration, Back Pain | Phase 1 | Status: RECRUITING